DNA

Based on decades of pharma and strategic consulting expertise

AESARA’s leadership team has held industry-based executive positions within Value & Access from small biotech to large pharmaceutical companies

Based on decades of pharma and strategic consulting expertise

AESARA’s leadership team has held industry-based executive positions within Value & Access from small biotech to large pharmaceutical companies

WHY?

What do they say about the need for integrated evidence planning (IEP)?

“At earlier stages of integration, companies still develop functional evidence generation plans bottom-up, and bring those plans together into an ‘integrated’ plan later. While this is a good starting basis does not allow for the most efficient use of resources. In addition, we notice that involvement of countries (timing and number) varies across the companies and is less systematic in terms of the involvement of smaller yet progressive countries.”
blood-drop

Clear

Single source of truth for your value proposition and value evidence

laptop-1

All in one place

Your complete repository for value propositions and supporting evidence

presentation-projector-screen-pie-chart

Tailored

PowerPoint presentation-ready output. Up-to-date product strategy slides on demand

ATLAS

Exciting news alert!

AESARA is excited to announce that ATLAS, your customizable solution for integrated evidence generation planning (IEGP) in pharma, is now AI-enabled! Meet with us to learn how to realize the benefits of leveraging AI in your IEGP. 

Ready to experience the future of integrated evidence generation planning? Join us at ISPOR or schedule a meeting to sign up for our three-month trial and continue exploring the potential of AI with us!

Summarize Evidence with Ease

Struggling to manage volumes of data in your evidence repository? ATLAS AI streamlines the process, prepopulating metadata fields and concisely summarizing publications trough a value and access lens.

Enhanced Alignment and Connectivity

ATLAS doesn’t just organize data it continues to enhance alignment across functions and geographies as well as connect evidence generation tactics with the value messages they support. Create a unified strategy with ATLAS, focused on long-term success. 

AI-assisted Value Proposition Framing

Let ATLAS AI take the first stab at framing your value propositionUsing your product value messages, ATLAS AI can generate a concise and targeted summary that communicates your product’s unique value and unmet needs it is addressing. 

OVERVIEW

ATLAS framework

Strategic roadmap to go from unmet need to patient access

Anchor to strategic positioning

Target product profile

Competitive landscape

Critical success factors

Market access goals

Anchor to strategic positioning

Target product profile

Competitive landscape

Critical success factors

Market access goals

Management dashboard to view and monitor KPIs

Enable leadership insights

Role-based access

Control based on roles and responsibilities

Data security

Vetted and approved by multiple pharma companies

OUTCOMES

Alignment

Align and organize value messaging, available evidence, and evidence generation activities

Identify data gaps to inform evidence generation planning and prioritization

job-choose-cadidate-1

Connectivity

Integrate evidence generation planning between clinical development and Value & Access

Adapt global Value & Access strategy for regional and country needs

Visibility

View all components of your Value & Access strategic thought process in one place

Protect institutional memory and capture evolution of Value & Access strategy over time

Where is your product roadmap?

Contact us

Fill out the form below, and we will be in touch shortly.